PCVX vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

PCVX

34.3
AI Score
VS
BBIO Wins

BBIO

50.0
AI Score

Investment Advisor Scores

PCVX

34score
Recommendation
SELL

BBIO

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCVX BBIO Winner
Net Income -604.92M -732.94M PCVX
Operating Income -648.63M -523.41M BBIO
ROE -21.9% 35.1% BBIO
ROA -19.3% -78.3% PCVX
Total Assets 3.14B 936.02M PCVX
Cash 183.19M 570.12M BBIO
Current Ratio 5.72 2.77 PCVX
Free Cash Flow -519.52M -447.01M BBIO

Relative Price Performance (Last 90 Days)

PCVX 1M: +12.5% · 3M: +32.1% BBIO 1M: -1.7% · 3M: +16.0%

Current Technical Phase

PCVX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.6% over 20 days), RSI 63

RSI (14): 62.5 · Price: $62.62

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $81.50

Fundamentals Snapshot

Metric PCVX BBIO
Market Cap
Forward P/E -8.4 532.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 1.2%
Gross Margin 0.9%
Operating Margin 0.0% -0.4%
EPS -8.07 -3.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.